FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Aplenc

Research Profile

Disorders

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Living Beings

Physiology

Concepts & Ideas

Activities & Behaviors

Health Information Systems

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Marko Kavcic; Grace E Lee; Yimei Li; Alix E Seif; Sarah K Tasian; Kari Torp; Marijana Vujkovic; Dana M Walker; Rochelle Bagatell; Brian T Fisher; Yuan-Shung Huang; Richard Aplenc
Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.
Lillian Sung; Todd A Alonzo; Richard Aplenc; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Nuala J Meyer; Grant E O'Keefe; Melanie Rushefski; Chau-Chyun Sheu; Paula Tejera; Mark M Wurfel; Yang Zhao; Richard Aplenc; Scarlett Bellamy; David C Christiani; Rui Feng; Robert Gallop; Paul N Lanken; Mingyao Li; Jason D Christie
IL1RN Coding Variant Is Associated with Lower Risk of Acute Respiratory Distress Syndrome and Increased Plasma IL-1 Receptor Antagonist.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Aplenc (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marko Kavcic; Grace E Lee; Yimei Li; Alix E Seif; Sarah K Tasian; Kari Torp; Marijana Vujkovic; Dana M Walker; Rochelle Bagatell; Brian T Fisher; Yuan-Shung Huang; Richard Aplenc
Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States.
Cancer 2013;119(10):1916-23.
2013: Lillian Sung; Todd A Alonzo; Richard Aplenc; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Blood 2013;121(18):3573-7.
2013: Nuala J Meyer; Grant E O'Keefe; Melanie Rushefski; Chau-Chyun Sheu; Paula Tejera; Mark M Wurfel; Yang Zhao; Richard Aplenc; Scarlett Bellamy; David C Christiani; Rui Feng; Robert Gallop; Paul N Lanken; Mingyao Li; Jason D Christie
IL1RN Coding Variant Is Associated with Lower Risk of Acute Respiratory Distress Syndrome and Increased Plasma IL-1 Receptor Antagonist.
American journal of respiratory and critical care medicine 2013;187(9):950-9.
2013: Susan E Puumala; Julie A Ross; Richard Aplenc; Logan G Spector
Epidemiology of childhood acute myeloid leukemia.
Pediatric blood & cancer 2013;60(5):728-33.
2013: Stephan A Grupp; Bernd Hauck; Richard Aplenc; David Barrett; Anne Chew; Michael Kalos; Bruce L Levine; Michael C Milone; David L Porter; Susan R Rheingold; David Teachey; J Fraser Wright; Carl H June
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
The New England journal of medicine 2013;368(16):1509-18.
2013: Dana M Walker; Brian T Fisher; Yuan-Shung V Huang; Yimei Li; Alix E Seif; Kari Torp; Richard Aplenc
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.
Pediatric blood & cancer 2013;60(4):616-20.
2013: Marko Kavcic; Yimei Li; Alix E Seif; Kari Torp; Marijana Vujkovic; Brian T Fisher; Yuan-Shung Huang; Richard Aplenc
Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database.
Pediatric blood & cancer 2013;60(3):508-11.
2013: Tammy I Kang; Russell Localio; Richard Aplenc; Kari Hexem; Chris Feudtner
The use of palliative chemotherapy in pediatric oncology patients: a national survey of pediatric oncologists.
Pediatric blood & cancer 2013;60(1):88-94.
2012: Meghan L Marsac; Anne Vinsel; Richard Aplenc; Lamia P Barakat; Kathleen Clawson; Aimee K Hildenbrand; Leela Jackson; Nancy Kassam-Adams; Kristen Kohser; Melissa A Alderfer
Acceptability and feasibility of family use of The Cellie Cancer Coping Kit.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(12):3315-24.
2012: Lillian Sung; Todd A Alonzo; Richard Aplenc; Alan S Gamis; Robert B Gerbing
Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group.
Haematologica 2012;97(11):1770-3.
2012: Richard Aplenc; David Bertoch; B T Fisher; Robert B Gerbing; M Hall; Y S Huang; R Keren; Y Li; A E Seif; L Sung; Peter Charles Adamson; Todd A Alonzo; Alan S Gamis
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.
Pharmacoepidemiology and drug safety 2012;21 Suppl 2():37-43.
2012: Dana M Sepe; Huaqing Zhao; Jinbo Chen; Meenakshi Devidas; Aaron Kershenbaum; Mei La; Beverly Lange; Thomas McWilliams; Timothy R Rebbeck; Richard Aplenc
Germline genetic variation and treatment response on CCG-1891.
Pediatric blood & cancer 2012;58(5):695-700.
2012: Soheil Meshinchi; Peter Charles Adamson; Richard Aplenc; Stephen P Hunger; J Milburn Jessup
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(6):1547-54.
2012: Nuala J Meyer; Melanie Rushefski; Michael G S Shashaty; Paul N Lanken; Richard Aplenc; Jason D Christie; Zhongyin John Daye; Rui Feng
SNP-set analysis replicates acute lung injury genetic risk factors.
BMC medical genetics 2012;13():52.
2012: Jason D Christie; Mitchell J Cohen; Rui Feng; Hakon Hakonarson; Cecilia Kim; Paul N Lanken; Mingyao Li; James P Maloney; Michael Matthay; Addison K May; Nuala J Meyer; Grant E O'Keefe; Jonathan Sevransky; Lorraine B Ware; Mark M Wurfel; Joshua M Akey; Richard Aplenc; Kathleen C Barnes; Jonathan Bradfield; Carolyn S Calfee; David C Christiani
Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma.
PloS one 2012;7(1):e28268.
2011: Robert M Sutton; Dana Niles; Benjamin S Abella; Richard Aplenc; Robert A Berg; Benjamin French; Mark A Helfaer; Evelyn L Lengetti; Peter A Meaney; Vinay Nadkarni
Low-dose, high-frequency CPR training improves skill retention of in-hospital pediatric providers.
Pediatrics 2011;128(1):e145-51.
2011: Nuala J Meyer; Mingyao Li; Rui Feng; Jonathan Bradfield; Robert Gallop; Scarlett Bellamy; Barry D Fuchs; Paul N Lanken; Steven M Albelda; Melanie Rushefski; Richard Aplenc; Helen Abramova; Elena N Atochina-Vasserman; Michael F Beers; Carolyn S Calfee; Mitchell J Cohen; Jean-Francois Pittet; David C Christiani; Grant E O'Keefe; Lorraine B Ware; Addison K May; Mark M Wurfel; Hakon Hakonarson; Jason D Christie
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio.
American journal of respiratory and critical care medicine 2011;183(10):1344-53.
2011: Robert M Sutton; Dana Niles; Peter A Meaney; Richard Aplenc; Benjamin French; Benjamin S Abella; Evelyn L Lengetti; Robert A Berg; Mark A Helfaer; Vinay Nadkarni
"Booster" training: evaluation of instructor-led bedside cardiopulmonary resuscitation skill training and automated corrective feedback to improve cardiopulmonary resuscitation compliance of Pediatric Basic Life Support providers during simulated cardiac arrest.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2011;12(3):e116-21.
2011: Richard Aplenc; Susan M Blaney; Lewis C Strauss; FRANK BALIS; Suzanne Shusterman; Ashish Mark Ingle; Shruti Agrawal; Junfeng Sun; John J Wright; Peter Charles Adamson
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(7):839-44.
2011: Kelsey A Johnson; Richard Aplenc; Rochelle Bagatell
Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005.
Pediatric blood & cancer 2011;56(3):425-31.
2011: Melanie Rushefski; Steven M Albelda; Richard Aplenc; Scarlett Bellamy; Sheldon I Feinstein; Rui Feng; Aron B Fisher; Robert Gallop; Paul N Lanken; Mingyao Li; A Russell Localio; Nuala Meyer; Jason D Christie
Novel variants in the PRDX6 Gene and the risk of Acute Lung Injury following major trauma.
BMC medical genetics 2011;12():77.
2011: Jun J Mao; Timothy R Rebbeck; Frank Stanczyk; H Irene Su; Richard Aplenc; Michelle L Donelson; Rui Feng; Angela DeMichele
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
Breast cancer research : BCR 2011;13(1):R8.
2010: Elizabeth Fox; Richard Aplenc; Rochelle Bagatell; Meredith K Chuk; Eva Dombi; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Nalini Jayaprakash; Marcelo Marotti; Kathryn H Brown; Barbara Wenrich; Peter Charles Adamson; BRIGITTE WIDEMANN; FRANK BALIS
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(35):5174-81.
2010: Brian T Fisher; Theoklis E Zaoutis; Kateri H Leckerman; Russell Localio; Richard Aplenc
Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study.
Pediatric blood & cancer 2010;55(4):655-61.
2010: Richard Aplenc
Steps forward in neuroblastoma genetic epidemiology.
Pediatric blood & cancer 2010;55(2):222-3.
2010: Jill P Ginsberg; Richard Aplenc; Joseph McDonough; James Bethel; John Doyle; Daniel J Weiner
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation.
Pediatric blood & cancer 2010;54(3):454-60.
2010: Priya P Gor; H Irene Su; Robert J Gray; Phyllis A Gimotty; Michelle Horn; Richard Aplenc; William P Vaughan; Martin S Tallman; Timothy R Rebbeck; Angela DeMichele
Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study.
Breast cancer research : BCR 2010;12(3):R26.
2009: Bella S Guerrouahen; Eric Wieder; Elisabeth G Blanchard; Francis Y Lee; Richard Aplenc; Seth J Corey
Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinib.
Pediatric blood & cancer 2009;53(6):1132-5.
2009: Brian T Fisher; Richard Aplenc; Russell Localio; Kateri H Leckerman; Theoklis E Zaoutis
Cefepime and mortality in pediatric acute myelogenous leukemia: a retrospective cohort study.
The Pediatric infectious disease journal 2009;28(11):971-5.
2009: Vladan Rajić; Richard Aplenc; Marusa Debeljak; Veronika Velensek Prestor; Natasa Karas Kuzelicki; Irena Mlinaric-Rascan; Janez Jazbec
Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood.
Leukemia & lymphoma 2009;50(10):1693-8.
2009: Thomas Lehrnbecher; Marie-Chantal Ethier; Theoklis Zaoutis; Ursula Creutzig; Alan Gamis; Dirk Reinhardt; Richard Aplenc; Lillian Sung
International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia.
British journal of haematology 2009;147(1):125-8.
2009: Anita J Reddy; Jason D Christie; Richard Aplenc; Barry Fuchs; Paul N Lanken; Steven R Kleeberger
Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury.
Journal of cellular and molecular medicine 2009;13(8B):1784-91.
2009: Angela DeMichele; Robert Gray; Michelle Horn; Jinbo Chen; Richard Aplenc; William P Vaughan; Martin S Tallman
Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.
Cancer research 2009;69(10):4184-91.
2008: Lillian Sung; Todd A Alonzo; Robert B Gerbing; Richard Aplenc; Beverly J Lange; William G Woods; James Feusner; Janet Franklin; Maria J Patterson; Alan S Gamis
Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer 2008;51(6):784-6.
2008: Robert Gross; Richard Aplenc; Thomas TenHave; Andrea S Foulkes; Rameshwari Thakur; Mosepele Mosepele; Jeffrey S Barrett; Charles Flexner; Brian L Strom; Gregory Bisson
Slow efavirenz metabolism genotype is common in Botswana.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):336-7.
2008: Jason D Christie; Shwu-Fan Ma; Richard Aplenc; Mingyao Li; Paul N Lanken; Chirag V Shah; Barry Fuchs; Steven M Albelda; Carlos Flores; Joe G. N. Garcia
Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma.
Critical care medicine 2008;36(10):2794-800.
2008: Lillian Sung; Richard Aplenc; Theo Zaoutis; Andreas H Groll; Brenda Gibson; Thomas Lehrnbecher
Infections in pediatric acute myeloid leukemia: lessons learned and unresolved questions.
Pediatric blood & cancer 2008;51(4):458-60.
2008: Nancy Bunin; Stella M Davies; Richard Aplenc; Bruce M Camitta; Kenneth B DeSantes; Rakesh K Goyal; Neena Kapoor; Nancy A Kernan; Joseph Rosenthal; Franklin O Smith; Mary Eapen
Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4326-32.
2008: Richard Aplenc; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; Craig A Hurwitz; Robert J Wells; Irwin D Bernstein; Patrick Buckley; Kathleen Krimmel; Franklin O Smith; Eric L Sievers; Robert J Arceci
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2390-3295.
2008: Sean Bulley; Adam Gassas; L Lee Dupuis; Richard Aplenc; Joseph Beyene; Mark L Greenberg; John J Doyle; Lillian Sung
Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation.
British journal of haematology 2008;140(2):214-7.
2008: Marusa Debeljak; Katarina Trebusak Podkrajsek; Richard Aplenc; Janez Jazbec
X-linked lymphoproliferative disease with a novel SH2D1A gene mutation.
Pediatric blood & cancer 2008;50(1):187.
2007: Angela DeMichele; Phyllis A Gimotty; Jeffrey Botbyl; Richard Aplenc; Theresa Colligon; Andrea S Foulkes; Timothy R Rebbeck
In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort".
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5675-7.
2007: Lea Cunningham; Richard Aplenc
Pharmacogenetics of acute lymphoblastic leukemia treatment response.
Expert opinion on pharmacotherapy 2007;8(15):2519-31.
2007: Jacqui M Marzec; Jason D Christie; SEKHAR POTHIREDDY; Anne E Jedlicka; Hue Vuong; Paul N Lanken; Richard Aplenc; Tae Yamamoto; Masayuki Yamamoto; Hye-Youn Cho; Steven R Kleeberger
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(9):2237-46.
2007: Parinda A Mehta; Mary Eapen; John P Klein; Sharavi Gandham; James Elliott; Tiffany Zamzow; Michelle Combs; Richard Aplenc; Margaret L MacMillan; Daniel J Weisdorf; Effie W Petersdorf; Stella M Davies
Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia.
British journal of haematology 2007;137(2):152-7.
2006: Richard Aplenc; Todd A Alonzo; Robert B Gerbing; Franklin O Smith; Soheil Meshinchi; Julie A Ross; John P Perentesis; William G Woods; Beverly J Lange; Stella M Davies
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Blood 2006;108(1):74-80.
2006: Nancy Bunin; Richard Aplenc; Stephan A Grupp; G Pierson; Dimitri S Monos
Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias.
Bone marrow transplantation 2006;37(2):143-9.
2005: Angela DeMichele; Richard Aplenc; Jeffrey Botbyl; Theresa Colligan; Lisa Wray; Melissa Klein-Cabral; Andrea Foulkes; Phyllis A Gimotty; John Glick; Barbara Weber; Edward A Stadtmauer; Timothy R Rebbeck
Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5552-9.
2005: Robert J Arceci; Jane Sande; Beverly Lange; Kevin Shannon; Janet Franklin; Raymond J Hutchinson; Terry A Vik; David A Flowers; Richard Aplenc; Mark S Berger; Matthew L Sherman; Franklin O Smith; Irwin D Bernstein; Eric L Sievers
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.
Blood 2005;106(4):1183-8.
2005: Janez Jazbec; Lidija Kitanovski; Richard Aplenc; Marusa Debeljak; Vita Dolzan
No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia.
Leukemia & lymphoma 2005;46(6):893-7.
2005: Dimitri S Monos; John Pappas; Eleni E Magira; John Gaughan; Richard Aplenc; Lazaros I Sakkas; Ralph Freedman; John D Reveille; Chris D Platsoucas
Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer.
Human immunology 2005;66(5):554-62.
2005: Richard Aplenc; Jennifer Thompson; Peggy Han; Mei La; Huaqing Zhao; Beverly Lange; Timothy R Rebbeck
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
Cancer research 2005;65(6):2482-7.
2005: Nancy Bunin; Richard Aplenc; Robert Iannone; AM Leahey; Stephan A Grupp; Dimitri S Monos; G Pierson
Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
Bone marrow transplantation 2005;35(4):369-73.
2005: Nancy Bunin; Richard Aplenc; AM Leahey; Eleni E Magira; Stephan A Grupp; G Pierson; Dimitri S Monos
Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias.
Bone marrow transplantation 2005;35(2):151-8.
2004: Charnita Zeigler-Johnson; Tara Friebel; Amy H Walker; Yiting Wang; Elaine Spangler; Saarene Panossian; Margerie Patacsil; Richard Aplenc; Alan J Wein; S Bruce Malkowicz; Timothy R Rebbeck
CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.
Cancer research 2004;64(22):8461-7.
2004: Richard Aplenc
Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children.
Pediatric blood & cancer 2004;43(5):539-41.
2004: Richard Aplenc; Beverly Lange
Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.
British journal of haematology 2004;125(4):421-34.
2004: J L Powell; Nancy Bunin; C Callahan; Richard Aplenc; G Griffin; Stephan A Grupp
An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma.
Bone marrow transplantation 2004;33(6):651-7.
2004: Beverly J Lange; Patricia A Dinndorf; Franklin O Smith; Carola Arndt; Dorothy Barnard; Stephen Feig; James Feusner; Nita L Seibel; Margie Weiman; Richard Aplenc; Robert B Gerbing; Todd A Alonzo
Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):150-6.
2003: Janez Jazbec; Richard Aplenc; Vita Dolzan; Marusa Debeljak; Berta Jereb
GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia.
Leukemia 2003;17(12):2540-2.
2003: Nancy Bunin; Richard Aplenc; Naynesh Kamani; K Shaw; Avital Cnaan; Steven Simms
Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
Bone marrow transplantation 2003;32(6):543-8.
2003: Richard Aplenc; Wendy Glatfelter; Peggy Han; Eric Rappaport; Mei La; Avital Cnaan; M Anne Blackwood; Beverly Lange; Timothy R Rebbeck
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia.
British journal of haematology 2003;122(2):240-4.
2003: Richard Aplenc; H Zhao; T R Rebbeck; K J Propert
Group sequential methods and sample size savings in biomarker-disease association studies.
Genetics 2003;163(3):1215-9.
2003: Richard Aplenc; Anil Vachani; Peggy Han; Wendy Glatfelter; Eric L Sievers
Pharmacogenetics of gemtuzumab-associated hepatic sinusoidal occlusion syndrome after hematopoietic stem cell transplant.
Acta haematologica 2003;110(4):207-10.
2002: Richard Aplenc; E Orudjev; Jennifer Swoyer; B Manke; T Rebbeck
Differential bone marrow aspirate DNA yields from commercial extraction kits.
Leukemia 2002;16(9):1865-6.
2002: Jenny M Kim; Junjie Fang; Susan R Rheingold; Richard Aplenc; Robert Wasserman; Stephan A Grupp
Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.
Cancer research 2002;62(15):4212-6.
2001: M J Fisher; A K Virmani; LI WU; Richard Aplenc; J C Harper; S M Powell; T R Rebbeck; David Sidransky; A F Gazdar; Wafik S El-Deiry
Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1688-97.
2001: P B Langmuir; Richard Aplenc; B J Lange
Acute myeloid leukaemia in children.
Best practice & research. Clinical haematology 2001;14(1):77-93.